Dermatitis News and Research

Latest Dermatitis News and Research

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.

12 May 2017

Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers

Cannabinoids contain anti-inflammatory properties that could make them useful in the treatment of a wide-range of skin diseases, according to researchers at the University of Colorado Anschutz Medical Campus.

18 Apr 2017

Scientists identify gene responsible for generating key lipid in skin barrier formation

Scientists have identified the gene responsible for generating acylceramide, the key lipid in forming the skin barrier that protects us from pathogens, allergens and other harmful substances. This finding could prove crucial in developing medicines for treating atopic dermatitis and ichthyosis.

17 Apr 2017

Silk garments unlikely to provide benefit for children with eczema

Wearing silk clothing offers no additional benefit for children who suffer from moderate to severe eczema, a study led by researchers at The University of Nottingham has found.

12 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

New treatment option could provide effective therapy for patients with dermatologic conditions

Alopecia areata, atopic dermatitis and vitiligo are highly visible dermatologic conditions that can have a negative effect on patients' quality of life and overall health. An emerging treatment option, however, could provide effective therapy for patients with these conditions.

3 Mar 2017

UC San Diego researchers suggest transplanting good bacteria to treat patients with atopic dermatitis

Healthy human skin is alive with bacteria. In fact, there are more microorganisms living in and on the human body than there are human cells. Most can live on the human skin without harming the host, but in some people bacteria can negatively alter their health, maybe even become life-threatening.

23 Feb 2017

New review examines use of probiotics or prebiotics for prevention of atopic dermatitis

Evidence supporting a key role for an altered gut microbiome in the development of atopic dermatitis would suggest that the use of probiotics or prebiotics to correct microbial imbalances in the gut could help prevent or treat AD.

31 Jan 2017

Contact dermatitis or contact eczema?

There is allergic contact dermatitis, which is mediated through an immune mechanism, this means that the person is specifically allergic to what they have come in to contact with their skin. Their body has had to go through a process whereby they have...

21 Dec 2016

FDA approves new treatment option for patients dealing with mild to moderate eczema

The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.

14 Dec 2016

New mathematical model suggests how AD may progress to become chronic

Successive flare-ups of the most common form of eczema may trigger an immune system overreaction, causing it to become a long-term condition in people.

8 Dec 2016

Study reveals why air pollutants cause some people to be at risk for atopic dermatitis

Tohoku University Graduate School of Medicine and Tohoku Medical Megabank Organization are pleased to announce the published results of a study into why air pollutants cause some people to be more susceptible to atopic dermatitis, a kind of skin inflammation.

29 Nov 2016

Common bacteria on human skin may offer protection against diseases

There are more and more examples of the ways in which we can benefit from our bacteria. According to researcher Rolf Lood from Lund University in Sweden, this is true for the skin as well.

11 Nov 2016

Wearable patch shows promise for treating children with peanut allergy

A wearable patch that delivers small amounts of peanut protein through the skin shows promise for treating children and young adults with peanut allergy, with greater benefits for younger children, according to one-year results from an ongoing clinical trial.

26 Oct 2016

New study finds no evidence of benefit from genetic disposition of eczema

Some genetic diseases persist for generation after generation because the genes that cause them can benefit human health.

6 Oct 2016

Study opens door towards personalized medicine for children with eczema

Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.

5 Oct 2016

Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Researchers for the first time have identified the skin phenotype of pediatric eczema or atopic dermatitis (AD) in infants, opening the door for personalized treatment approaches for young children with eczema.

23 Sep 2016

Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

One of the major complications of diabetes is the appearance of wounds in the lower extremities that do not heal properly.

31 Aug 2016

MRSA correlated to eczema? An interview with Dr Bjorn Herpers

There is a lot of evidence that Staphylococcus aureus (S. aureus) is involved in eczema. Eczema is now thought to be caused by a barrier dysfunction of the skin that allows external triggers to cause an overshoot of inflammation.

31 Aug 2016

Cases of rotavirus infections fall by 84% thanks to vaccination

Figures published by Public Health England have shown that the number of diagnosed Rotavirus cases, a highly infectious virus which may cause vomiting and diarrhoea, have dropped by 84% since the introduction of a vaccine to the national childhood immunisation schedule in July 2013.

29 Aug 2016

Dermatitis News and Research

Latest Dermatitis News and Research

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers

Scientists identify gene responsible for generating key lipid in skin barrier formation

Silk garments unlikely to provide benefit for children with eczema

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

New treatment option could provide effective therapy for patients with dermatologic conditions

UC San Diego researchers suggest transplanting good bacteria to treat patients with atopic dermatitis

New review examines use of probiotics or prebiotics for prevention of atopic dermatitis

Contact dermatitis or contact eczema?

FDA approves new treatment option for patients dealing with mild to moderate eczema

New mathematical model suggests how AD may progress to become chronic

Study reveals why air pollutants cause some people to be at risk for atopic dermatitis

Common bacteria on human skin may offer protection against diseases

Wearable patch shows promise for treating children with peanut allergy

New study finds no evidence of benefit from genetic disposition of eczema

Study opens door towards personalized medicine for children with eczema

Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

MRSA correlated to eczema? An interview with Dr Bjorn Herpers

Cases of rotavirus infections fall by 84% thanks to vaccination

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Dermatitis News and Research

Latest Dermatitis News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in